With AstraZeneca since 2019, Alex previously served as Regional Commercial Director for Respiratory and Immunology within the company’s EUCAN team.
Before joining AstraZeneca, Alex accumulated over 18 years of experience in senior leadership roles at Hoffmann-La Roche, Eli Lilly, and Merck, including positions such as Global Commercial Head of Immunology and Rare Diseases in Basel and Franchise Head for Immunology in the UK.
Alex holds a B.Sc. in Anatomy and Physiology from the University of Leeds and an M.B.A. from Manchester Business School.